A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis. (Q48062998)
Jump to navigation
Jump to search
scientific article published on 23 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis. |
scientific article published on 23 February 2016 |
Statements
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis (English)
K Reich
A Blauvelt
W Baran
C Bolduc
D Toth
R G Langley
J Cather
A B Gottlieb
D Thaçi
J G Krueger
C E Milmont
J Li
P A Klekotka
G Kricorian